World Federation of Hemophilia
1425 Rene Levesque Boulevard West
Suite 1010
Montreal
Quebec
H3G 1T7
Canada
Tel: 514-875-7944
Fax: 514-875-8916
Website: http://www.wfh.org/
Email: wfh@wfh.org
20 articles about World Federation of Hemophilia
-
Organizations Collaborate to Develop International State-of-the-Art Guidelines on the Diagnosis and Management of von Willebrand Disease
1/12/2021
The American Society of Hematology, the International Society on Thrombosis and Haemostasis, National Hemophilia Foundation, and World Federation of Hemophilia have developed joint clinical practice guidelines on the diagnosis and management of von Willebrand Disease, the world's most common inherited bleeding disorder.
-
Orthopaedic Institute for Children’s Medical Director Mauricio Silva, M.D., Speaks at Hemophilia Conference in Jordan
10/24/2019
Mauricio Silva, M.D., medical director at Los Angeles’ Orthopaedic Institute for Children, was one of a select group of trainers invited by the World Federation of Hemophilia to travel to Amman, Jordan, and participate at the Federation’s Regional Musculoskeletal Workshop for the Eastern Mediterranean Region.
-
In addition to education and training, it will offer Bayer’s complete portfolio of recombinant Factor VIII treatments to healthcare providers in more than 60 countries.
-
CSL Behring Extends Support of World Federation of Hemophilia Programs
2/4/2019
Reinforces Commitment to Providing Global Bleeding Disorders Community with Access to Care and Efforts to Increase Awareness
-
Shire Release: ADYNOVATE Phase 3 Efficacy And Safety Data In Children To Be Showcased During International Congress Of The World Federation of Hemophilia
7/26/2016
-
CSL Behring Presents Phase III Data For IDELVION For Hemophilia B At The World Federation of Hemophilia 2016 World Congress
7/26/2016
-
Alnylam To Report New Clinical Results With Fitusiran At The World Federation of Hemophilia 2016 World Congress
7/25/2016
-
CSL Behring To Present New Data For IDELVION And AFSTYLA At The World Federation of Hemophilia 2016 World Congress
7/19/2016
-
CSL Behring Continues Commitment To Donate Bleeding Disorder Medications To World Federation of Hemophilia
4/17/2014
-
CSL Behring Donates Medicine Used in Treating Bleeding Disorders to World Federation of Hemophilia
4/4/2013
-
Pfizer Inc. Donates Vials of Factor IX to the World Federation of Hemophilia to Help Developing Countries
10/25/2012
-
Octapharma AG Hosts Symposium at World Federation of Hemophilia World Congress on "Personalizing the Inhibitor Treatment and Prevention" in Hemophilia A
7/25/2012
-
Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at World Federation of Hemophilia 2012 World Congress
7/9/2012
-
CSL Behring Marks World Hemophilia Day with Coagulation Factor Donation to World Federation of Hemophilia
2/16/2011
-
Biogen Idec, Inc. (Massachusetts) and Swedish Orphan Biovitrum Present Data on Long-Lasting Hemophilia B Therapy at the World Federation of Hemophilia Congress
7/12/2010
-
CSL Behring Marks World Hemophilia Day with $2M Coagulation Factor Donation to World Federation of Hemophilia
4/17/2009
-
Baxter International, Inc. Partners with World Federation of Hemophilia to Heighten Awareness of Vital Role of Comprehensive Care in Hemophilia Management and Global Disparities in Care
4/16/2009
-
Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 World Federation of Hemophilia World Congress; Company Announces Winners of the 'It's Your Passion. Let It Out' Contest
6/4/2008
-
Talecris Biotherapeutics Provides Educational Grant to Support World Federation of Hemophilia's Global Laboratory Science Program
5/3/2007
-
Bayer HealthCare Pharmaceuticals Provides Euro 250.000 Grant to the World Federation of Hemophilia to Support Innovative Patient Care Research and Educational Initiatives
4/16/2007